Hui, E P <br/><br/>
Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Jun 2011 
 - 1280-1287 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdq629  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--adverse effects<br/>Carcinoma<br/>Chemoradiotherapy<br/>Epistaxis--chemically induced<br/>Female<br/>Hematemesis--chemically induced<br/>Hemoptysis--chemically induced<br/>Humans<br/>Indoles--adverse effects<br/>Male<br/>Middle Aged<br/>Nasopharyngeal Carcinoma<br/>Nasopharyngeal Neoplasms--therapy<br/>Pyrroles--adverse effects<br/>Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors<br/>Sunitinib<br/>Treatment Outcome